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Xanthomonas oryzae pv. oryzicola (Xoc) causes bac-
terial leaf streak (BLS) disease on rice plants. Xoc de-
livers a type III effector AvrRxo1-ORF1 into rice plant
cells that can be recognized by disease resistance
(R) protein Rxo1, and triggers resistance to BLS
disease. However, the mechanism and virulence
role of AvrRxo1 is not known. In the genome of
Xoc, AvrRxo1-ORF1 is adjacent to another gene
AvrRxo1-ORF2, which was predicted to encode a
molecular chaperone of AvrRxo1-ORF1. We report
the co-purification and crystallization of the
AvrRxo1-ORF1:AvrRxo1-ORF2 tetramer complex at
1.64 A˚ resolution. AvrRxo1-ORF1 has a T4 polynucle-
otide kinase domain, and expression of AvrRxo1-
ORF1 suppresses bacterial growth in a manner
dependent on the kinase motif. Although AvrRxo1-
ORF2 binds AvrRxo1-ORF1, it is structurally different
from typical effector-binding chaperones, in that it
has a distinct fold containing a novel kinase-binding
domain. AvrRxo1-ORF2 functions to suppress the
bacteriostatic activity of AvrRxo1-ORF1 in bacterial
cells.
INTRODUCTION
A common feature of Gram-negative bacterial pathogens of
plants or animals is the use of evolutionarily conserved type III
secretion systems (T3SS) to deliver effectors (T3Es) into host
cells in order to suppress host immunity (Abramovitch et al.,
2006; Ausubel, 2005; Chisholm et al., 2006; Jones and Dangl,
2006). Efficient secretion of some T3Es requires T3S chaper-
ones, which bind to the N terminus of the cognate effector (Par-
sot et al., 2003; Singer et al., 2004). While in many plant patho-
gens chaperones are encoded downstream of the effector in1900 Structure 23, 1900–1909, October 6, 2015 ª2015 Elsevier Ltd Athe same operon, Xanthomonas sp. typically encode a single
chaperone, HpaB, that binds to multiple effectors. Most T3E-
binding chaperones share a high degree of structural homology
despite having divergent amino acid sequences (Parsot et al.,
2003).
In some plant pathosystems, plants evolved disease resis-
tance genes (R) to specifically recognize cognate T3Es and
trigger a disease resistance response that frequently culminates
in a hypersensitive response, which consists in programmed cell
death and other concomitant plant responses (Chisholm et al.,
2006). This interaction is also referred to as effector-triggered im-
munity (Boller and He, 2009). Most cloned R genes encode
structurally conserved nucleotide-binding domain and leucine-
rich repeat (NB-LRR) proteins (Bai et al., 2002; Ellis et al.,
2000; Meyers et al., 2003, 2005). However, in contrast to the
conserved structural similarity of plant R proteins, microbial
T3Es share little structural or sequence homology (Chang
et al., 2005; Potnis et al., 2011; Stavrinides et al., 2006; Thieme
et al., 2005), and it is difficult to predict their biochemical func-
tions based on the primary protein sequence. Some of the bac-
terial T3Esmay suppress host immunity through a variety of stra-
tegies, including functional mimicry of proteins in the host cell.
However, the majority of effectors do not have predicted
biochemical functions. Solved three-dimensional (3D) structures
of pathogen effectors have been key in identification of the puta-
tive functions of several effectors (Boutemy et al., 2011; Chou
et al., 2011; Janjusevic et al., 2006; Lee et al., 2004; Singer
et al., 2004; Wang et al., 2007; Wirthmueller et al., 2013). For
example, the resolved structures of AvrPtoB and XopL led to
the identification of unique E3 ligase domains that were not iden-
tifiable from their amino acid sequences (Janjusevic et al., 2006;
Singer et al., 2013).
Rice bacterial leaf streak (BLS) disease, caused by Xanthomo-
nas oryzae pv. oryzicola (Xoc), is one of the most important bac-
terial diseases in rice (Nino-Liu et al., 2006; Salzberg et al., 2008;
Zhao et al., 2004a, 2004b, 2005). Almost all rice cultivars, espe-
cially hybrid rice cultivars, are highly susceptible to BLS (Nino-
Liu et al., 2006; Zhao et al., 2004b). We previously isolated a
T3E gene, avrRxo1-ORF1, from the genome of Xoc (Zhaoll rights reserved
et al., 2004b). AvrRxo1-ORF1 is conserved among all Asian Xoc
strains tested (Zhao et al., 2004b). Although no major BLS dis-
ease resistance genes have been found in rice germplasm,
AvrRxo1-ORF1 is recognized by the maize NB-LRR resistance
protein Rxo1, which triggers disease resistance in both maize
and transgenic rice plants (Zhao et al., 2005). In all Xoc strains
tested, avrRxo1-ORF1 is encoded directly upstream of
avrRxo1-ORF2, predicted to encode a small protein that was hy-
pothesized to act as a chaperone of AvrRxo1-ORF1 (Zhao et al.,
2004b). The virulence role and molecular host targets of
AvrRxo1-ORF1 are unknown, but AvrRxo1 has been reported
to be toxic to both yeast and plant cells (Liu et al., 2014; Salomon
et al., 2011; Zhao et al., 2004b). AvrRxo1-ORF1 and AvrRxo1-
ORF2 have no significant sequence homology to known proteins
in protein databases, and themolecular interactions between the
proteins are unknown. Therefore, a structural understanding of
AvrRxo1-ORF1 and AvrRxo1-ORF2 would provide insight to
themolecular mechanism of AvrRxo1’s growth-inhibitory capac-
ity and of AvrRxo1/Rxo1-mediated disease resistance.
In the present study, we determined the crystal structures of
a heterotetramer complex formed by AvrRxo1-ORF1 and
AvrRxo1-ORF2. In addition to its toxicity to plant cells, we found
that AvrRxo1-ORF1 contributes to X. oryzae proliferation on rice
plants, and strongly suppresses bacterial growth in the absence
of AvrRxo1-ORF2. AvrRxo1-ORF1 is a T4-polynucleotide kinase
domain-containing protein with conserved catalytic sites
required for virulence and toxicity. AvrRxo1-ORF2, which has
no structural similarity to characterized T3S effector-binding
chaperones (Parsot et al., 2003), contains a novel kinase
domain-binding fold.
RESULTS AND DISCUSSION
Determination of the Crystal Structures
of AvrRxo1-ORF1:AvrRxo1-ORF2 Complexes
Purification of AvrRxo1-ORF1 after expression in Escherichia
coli cells was problematic because the protein was toxic to
E. coli. However, co-expression of AvrRxo1-ORF1 with
AvrRxo1-ORF2 resulted in a stable and soluble protein complex,
allowing purification of the AvrRxo1-ORF1:ORF2 complex of
both native and selenomethionine-substituted proteins. The first
crystal of selenomethionine-substituted AvrRxo1-ORF1:ORF2
complex (Se-Met-AvrRxo1-ORF1:AvrRxo1-ORF2) was dif-
fracted to 1.88 A˚. The structure was solved using the single-
wavelength anomalous dispersion (SAD) method. Five selenium
sites were found in the structure with hkl2map, giving an overall
figure of merit of 0.5 calculated by PHENIX.Autosol. The further
PHENIX run using AutoBuild resulted in an initial model with
more than 75% of the residues built. This model was subjected
to iterative cycles of refinement and model rebuilding until the
final model reached acceptable parameters in geometry and
fitting. N-AvrRxo1-ORF1:AvrRxo1-ORF2 (2.30 A˚, native crystal
of AvrRxo1-ORF1:AvrRxo1-ORF2 complex), SO4-AvrRxo1-
ORF1:AvrRxo1-ORF2 (1.64 A˚, crystallized in ammonium sulfate
salt), and ATP-AvrRxo1-ORF1:AvrRxo1-ORF2 (1.64 A˚, co-crys-
tallized with ATP and magnesium acetate) crystal structures
were solved by molecular replacement using the solved
Se-Met:AvrRxo1-ORF1:AvrRxo1-ORF2 complex structure as a
searchmodel. The data collection, refinement statistics, and sta-Structure 23, 1900–tistics on Ramachandran plots as defined with MolProbity (Chen
et al., 2010) of the four crystal structures are provided in Table 1.
The Complex Formation and the Interaction Interfaces
between AvrRxo1-ORF1 and -ORF2
The complex proteins have a molecular weight of around
100 kDa compared with protein standards in gel-filtration chro-
matography (Figure S1). Based on the molecular weight, the
complex may consist of two AvrRxo1-ORF1 and two AvrRxo1-
ORF2 molecules, and therefore appears to form a heterote-
tramer. The structure of N-AvrRxo1-ORF1:AvrRxo1-ORF2
complex is depicted in Figures 1A and 1B. The complex is a het-
erotetramer analyzed by PISA (Krissinel and Henrick, 2007),
which is consistent with the gel-filtration results. AvrRxo1-
ORF1 and AvrRxo1-ORF2 form a compact heterodimer (Fig-
ure 1C), and two heterodimers form a tetramer with 2-fold
rotational symmetry (Figure 1A). In the N-AvrRxo1-ORF1:
AvrRxo1-ORF2 structure, the interface area between AvrRxo1-
ORF1 and AvrRxo1-ORF2 is 1,608 A˚2, the interface area be-
tween AvrRxo1-ORF2 and AvrRxo1-ORF2 is 988 A˚2, and the
interface area between AvrRxo1-ORF1 and AvrRxo1-ORF1 is
279 A˚2. The lists of hydrogen bonds and salt bridges in the
interfaces were generated using PISA. There are 18 hydrogen
bonds and nine salt bridges between AvrRxo1-ORF1 and
AvrRxo1-ORF2 molecules, four hydrogen bonds and four salt
bridges between two AvrRxo1-ORF2 molecules, and no
hydrogen bond and salt bridge formed between two AvrRxo1-
ORF1 molecules in the N-AvrRxo1-ORF1:AvrRxo1-ORF2 com-
plex (Table S1).
By comparing the interface areas and number of hydrogen
bonds and salt bridges involved in the complex formation of
the following four complex structures, we did not observe
major differences between N-AvrRxo1-ORF1:AvrRxo1-ORF2
and SO4-AvrRxo1-ORF1:AvrRxo1-ORF2, and between native
and selenomethionine-substituted proteins (N-AvrRxo1-ORF1:
AvrRxo1-ORF2 and Se-Met-AvrRxo1-ORF1:AvrRxo1-ORF2).
However, when co-crystallized with ATP and Mg2+ (ATP-
AvrRxo1-ORF1:AvrRxo1-ORF2), the complex is very different
from the previous complexes regarding the interface areas, num-
ber of hydrogen bonds, and salt bridges involved in complex for-
mation. The molecules bind more tightly to one another in the
ATP-AvrRxo1-ORF1:AvrRxo1-ORF2 complex than in other com-
plexes based on interface areas and numbers of hydrogen
bonds, and eight salt bridges (Table S2). A high concentration
of phosphate or sulfate favors the growth of crystals. Although
the ATP might be the favored active-site ligand in native condi-
tions, crystallization conditionsmight cause sulfate or phosphate
to occupy the binding site instead. Since we did not see an elec-
tron density corresponding to ATP and Mg2+ in the complex, it is
not clear how ATP and Mg2+ affect the molecule interaction. To
determine whether ATP and Mg2+ could affect conformational
change inside each individual molecule, we carried out a com-
parison of four complexes, which may provide a valuable insight
into the dynamics of the molecular interaction in the complex. A
superposition of four independent AvrRxo1-ORF1:AvrRxo1-
ORF2 complexes can be seen in Figure 1B, and the regions
that are less conformationally constrained are illustrated in
the figure.These significant conformational changes include
two parts of the AvrRxo1-ORF1 molecule and one of the1909, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1901
Table 1. Data Collection and Refinement Statistics of Native-AvrRxo1-ORF1:ORF2 (N-AvrRxo1-ORF1:ORF2), selenomethionine-
AvrRxo1-ORF1:ORF2 (Se-Met-AvrRxo1-ORF1:ORF2), SO4-AvrRxo1-ORF1:ORF2, and ATP-AvrRxo1-ORF1:ORF2 Complexes
Crystal Data Se-Met-AvrRxo1-ORF1:ORF2 N-AvrRxo1-ORF1:ORF2 SO4-AvrRxo1-ORF1:ORF2 ATP-AvrRxo1-ORF1:ORF2
Space group C2221
Unit cell
a (A˚) 75.6 75.3 75.4 75.2
b (A˚) 88.9 88.4 88.4 88.4
c (A˚) 153.5 152.5 152.7 152.7
a = g = b () 90.0
Data Collection
X-Ray source BNLa-X29
Wavelength (A˚) 0.979 1.075 1.075 1.075
Resolution (A˚)b 1.88 (1.95–1.88) 2.30 (2.38–2.30) 1.64 (1.70–1.64) 1.64 (1.70–1.64)
Total no. of reflections 575,588 167,063 966,532 491,873
No. of unique reflections 41,704 23,006 63,004 62,831
Rmerge
b 0.09 (0.55) 0.13 (0.62) 0.08 (0.53) 0.09 (0.77)
I/sI 26.7 (7.9) 15.9 (3.1) 33.7 (4.9) 20.3 (1.5)
CC1/2 0.98 (0.91) 0.99 (0.95) 0.95 (0.74)
Redundancyb 13.9 (9.7) 7.3 (7.2) 15.5 (13.6) 5.5 (7.9)
Completeness (%)b 99.4 (97.0) 100.0 (100.0) 99.0 (90.1) 98.6 (85.7)
Refinement Statistics
Rwork (%) 22.6 20.2 20.2 20.0
Rfree (%) 27.3 24.1 22.2 23.6
RMS bond lengths (A˚) 0.011 0.013 0.010 0.024
RMS bond angles () 1.401 1.448 1.145 2.043





No. of water molecules 327 156 378 322
Average B factor overall (A˚2) 32.7 37.5 30.0 32.4
Statistics on Ramachandran plot (%)
Most favored regions 92.8 92.3 95.6 95.6
Additional allowed regions 7.2 7.4 4.4 4.4
Generously allowed regions 0 0.3 0 0.1
See also Tables S1, S2, and S3. ACT, acetate ion; GOL, glycerol; PO4, phosphate ion; SO4, sulfate ion.
aBrookhaven National Laboratory.
bValues in parentheses are for the highest-resolution shell.AvrRxo1-ORF2 molecule (Figure 1C). The conformational
changes are not associated with ligand binding or crystallization
conditions.
Structural Features of AvrRxo1-ORF1 and Its Function
A Dali search (Holm et al., 2006) with the AvrRxo1-ORF1 struc-
ture revealed that AvrRxo1-ORF1 is most similar to Zeta toxin
protein, a toxin from Streptococcus pyogenes (Meinhart et al.,
2003) (PDB: 1GVN; Z = 16.6, root-mean-square deviation
[rmsd] = 3.4, sequence identity = 12%). The Dali search result
listed eight unique proteins (40 different chains) with Z score
higher than 9.2. All eight proteins have a P loop (Figure S2B), a
common motif in ATP- and GTP-binding proteins, and have
been assigned as kinases or phosphotransferases (Bernstein1902 Structure 23, 1900–1909, October 6, 2015 ª2015 Elsevier Ltd Aet al., 2005; Galburt et al., 2002; Khoo et al., 2007; Mutschler
et al., 2011; Sherrer et al., 2011; Wang et al., 2002; Yuen et al.,
1999). 3D alignments of eight kinase structures and AvrRxo1-
ORF1 revealed that they all have common fold core structures
of the N-terminal kinase domain of T4 polynucleotide kinase
(T4pnk) from an enterobacteria phage (Wang et al., 2002)
(PDB: 1LYL; Z = 10.0, rmsd = 2.8, sequence identity = 13%),
which are conserved despite structure-based sequence align-
ments that reveal very low pairwise sequence identity.
AvrRxo1-ORF1 is composed of a conserved T4pnk domain
flanked by additional N-terminal and C-terminal domains. The
N-terminal domain of AvrRxo1-ORF1 consists of one long a helix
and two short a helices, the latter of which are involved in com-
plex formation. The C-terminal domain is also involved inll rights reserved
Figure 1. Assembly of AvrRxo1-ORF1:AvrRxo1-ORF2 Complex and
Regions Having Significant Conformational Changes Revealed by
a Comparison of Four Complex Structures
(A) Twomolecules of AvrRxo1-ORF1 are presented in the surface presentation
with light-gray color. Two molecules of AvrRxo1-ORF2 are shown in cartoon
presentation as yellow and cyan. The lower image is a view of a 90 horizontal
rotation of the top view.
(B) Tetramer organization of AvrRxo1-ORF1:ORF2 complex. In the complex
both AvrRxo1-ORF1 and -ORF2 are involved in tetramer formation.
(C) A superposition of all four complexes, with the backbones shown in ribbon
presentation. AvrRxo1-ORF1 is shown in green, AvrRxo1-ORF2 in cyan, and
regions having conformational changes in red.
See also Figures S1, S2, and S5.
Figure 2. Structural Fold and Putative Active-Site Residues of
AvrRxo1-ORF1
One AvrRxo1 molecule in the complex is shown in cartoon presentation while
other parts of the complex are in surface presentation colored light green.
(A) AvrRxo1 consists of three major domains: N-terminal domain (blue), T4pnk
kinase domain (green), and C-terminal domain (cyan). The P loop is red.
(B) A superposition of AvrRxo1 (green) and the T4pnk kinase domain (PDB:
1LYL) (brown). Key residues for T4pnk kinase catalysis identified previously
are shown as sticks, with carbon (brown), oxygen (red), and nitrogen (blue)
atoms. The equivalent residues fromAvrRxo1 are shown as sticks, with carbon
(green), oxygen (red), and nitrogen (blue) atoms. See also Figure S2.complex formation, and is composed of three b strands and
three major helices (Figure 2A). The T4pnk kinase domain con-
sists of a four-strand b sheet surrounded by six a helices (Fig-
ure S2A), and a P loop (Figures S2B and 2A). All AvrRxo1-
ORF1 structures from the four complexes reported here bind
either two phosphate or two sulfate ions in the putative ATP-
binding site revealed by T4pnk structures (Galburt et al., 2002;
Wang et al., 2002) (Figures 3 and S3). By superimposing all
four complex structures, we noticed that phosphate (Figures
3A and 3C) and sulfate ions (Figures 3B and 3C) occupied slightly
different positions in AvrRxo1-ORF1. Based on the phosphate-
and sulfate-binding information, we defined an ATP-binding
site using molecular docking. Interestingly, one of the phosphate
ions occupied the g-phosphate position of ATP and one of the
sulfate ions occupied the a-phosphate position of ATP (Fig-
ure 3D). The phosphate or sulfate ions occupied the ATP-binding
site of AvrRxo1-ORF1, likely resulting in steric hindrance that
prevented ATP interaction and co-crystallization with AvrRxo1-
ORF1.
The T4pnk kinase domain catalyzes the transfer of the g-phos-
phate from ATP or other nucleoside triphosphates to the 50-OH
terminus of DNA, RNA, and nucleoside 30-monophosphates
(Wang and Shuman, 2002). Residues K15, S16, D35, R38, and
R126 in T4pnk are key residues responsible for its kinase activity
(Wang and Shuman, 2001, 2002). Interestingly, all of the other
eight structures shown in Figure S1 share conserved T4pnk
active-site residues. AvrRxo1-ORF1 has equivalent residues
K166 (K15), T167 (S16), D193 (D35), K196 (R38), and R287
(R126), which fold and occupy positions similar to those in the
key active-site residues in T4pnk (Figure 2B). The substrate-
binding sites of the T4pnk kinase domain have been identified
(Eastberg et al., 2004). A superposition of AvrRxo1-ORF1 ontoStructure 23, 1900–the T4pnk kinase domain revealed that AvrRxo1-ORF1 has a
site for nucleotide binding similar to that of the T4pnk kinase
domain (Figure 4B). We used HADDOCK Protein-DNA docking
(de Vries et al., 2010) to see whether the same T4pnk-binding
substrate, a single-strand trinucleotide (GTC), can be docked
to the similar position of AvrRxo1-ORF1. The docking result
showed that the binding site (Figures 4B and 4C) with the
best HADDOCK score (Table S3) is similar to the binding site
of GTC in the T4pnk kinase domain (Figure 4). Interestingly,
this nucleotide-binding cavity is occupied by AvrRxo1-ORF2
in the complex, and renders AvrRxo1-ORF1 in the complex
in an inactive form. Based on the structure of AvrRxo1-
ORF1, it is highly likely that AvrRxo1-ORF1 is a kinase of an
unknown substrate, and that AvrRxo1-ORF2 blocks the kinase
activity.
To determine whether key catalytic sites important for kinase
activity of T4pnk correspond to sites important to AvrRxo1-
ORF1 activity, AvrRxo1-ORF1 was inactivated at the sites of
the predicted substrate-binding residue D193 or the ATP-bind-
ing residue T167. Since AvrRxo1-ORF1 has structural similarity
to Zeta toxin, a microbial toxin that inhibits the proliferation of
E. coli (Mutschler et al., 2011), we tested the effect of
AvrRxo1-ORF1 expression on the growth of E. coli. As shown
in Figure 5A, expression of AvrRxo1-ORF1 inhibits bacterial
growth, and this activity is abolished by mutations of the pre-
dicted substrate-binding residue D193 or the ATP-binding resi-
due T167. Therefore, wild-type AvrRxo1 indeed possesses a
growth-suppressive function that depends on its putative kinase
activity. AvrRxo1-ORF1 bacteriostatic activity is inhibited by co-
expression with AvrRxo1-ORF2 (Figure 5A), consistent with the
structural placement of AvrRxo1-ORF2 at the predicted sub-
strate-binding site. The conserved kinase domain suggests
that AvrRxo1-ORF1 phosphorylates substrates that are critical
for bacterial growth.
Because AvrRxo1-ORF1 has structural similarity to Zeta toxin,
which was recently proved to possess a uridine diphosphate-N-
acetylglucosamine (UNAG) kinase activity that inhibits bacterial1909, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1903
Figure 3. Binding Sites of Phosphate Ions,
Sulfate Ions, and ATP in the AvrRxo1-ORF1
Active Center
Parts of the AvrRxo1-ORF1 structures are shown
in ribbon presentation in green, and P loops are
shown in magenta.
(A) Phosphate ion binding sites in the active center
of the AvrRxo1 molecule from the N-AvrRxo1-
ORF1:ORF2 structure. Residues around 4 A˚ of two
phosphate ions are shown as sticks, and residue
numbers are labeled.
(B)Sulfate ionbindingsites in theactivecenterof the
AvrRxo1 molecule from the SO4-AvrRxo1-ORF1:
ORF2 structure. Residues around 4 A˚ of two sulfate
ions are shown as sticks, and residue numbers are
labeled.
(C)Superposition of all four complexes. Thephosphate ion (orange) binding sites, seen inN-AvrRxo1-ORF1:ORF2 andSe-Met-AvrRxo1-ORF1:ORF2structures, are
similar, and the sulfate ion (yellow) binding sites, revealed in SO4-AvrRxo1-ORF1:ORF2 and ATP-AvrRxo1-ORF1:ORF2 structures, are the same.
(D) A superposition of the AvrRxo1-ORF1:ATP complex obtained by molecular docking onto the four superimposed structures shown in (C). Note that one of the
phosphate ions occupied the g-phosphate position of ATP and one of the sulfate ions occupied the a-phosphate position of ATP.
See also Figure S3.peptidoglycan formation (Mutschler et al., 2011), we also at-
tempted to test whether AvrRxo1 phosphorylates UNAG
in vitro. Since AvrRxo1-ORF1 alone is toxic and cannot be puri-
fied from E. coli,we therefore tried to express both wild-type and
mutant AvrRxo1 and Zeta toxin by using the wheat-germ in vitro
translation system. The purified proteins were used for a UNAG
kinase assay as described byMutschler et al. (2011). As shown in
Figure S4, the in vitro translated AvrRxo1-ORF1 did not have
ATPase activity in the presence of UNAG, but Zeta toxin did un-
der the same testing condition (Mutschler et al., 2011). There-
fore, we conclude that AvrRxo1 does not possess the UNAG
kinase activity.
In addition to inhibiting bacterial growth, AvrRxo1-ORF1 also
triggers T167-dependent plant cell death after transient expres-
sion in diverse plant species (Figure 5B). Interestingly, the cell
death phenotype triggered by AvrRxo1-ORF1 can be completely
inhibited by the co-expression of AvrRxo1-ORF2 (Figure 5C).
This may suggest that AvrRxo1-ORF1 has a phosphorylation
target that is conserved in prokaryotes and eukaryotes, and
that AvrRxo1-ORF2 may function as antitoxin to inhibit the puta-
tive kinase active of AvrRxo1-ORF1 in both prokaryotes and
eukaryotes.
To test whether AvrRxo1 enhances the Xanthomonas bacterial
virulence and whether the virulence function depends on the ki-
nase domain of AvrRxo1, we introduced a plasmid that contains
either the native AvrRxo1-ORF1:ORF2 gene (Zhao et al., 2004b)
or mutant AvrRxo1-ORF1-T167N:ORF2 gene into the X. oryzae
strain X11-5A. X11-5A is a weakly virulent X. oryzae strain
isolated in the United States (Triplett et al., 2011). As shown in
Figure 5C, when inoculated on rice plants (cv. Kitaake), popula-
tions of X11-5A carrying wild-type AvrRxo1-ORF1:ORF2 in-
crease to higher numbers than X. oryzae strain X11-5A carrying
AvrRxo1-ORF1-T167N:ORF2 after 2 days. Surprisingly, the
ATP-binding site mutant reached higher population numbers
than the vector control, possibly because the mutant protein
retained ability to bind and sequester the hypothetical phosphor-
ylation target. Thus, AvrRxo1 functions to enhance bacterial
multiplication in plants, and full virulence function is dependent
on its putative kinase activity.1904 Structure 23, 1900–1909, October 6, 2015 ª2015 Elsevier Ltd AStructural Features of AvrRxo1-ORF2
A Dali search (Holm et al., 2006) with the AvrRxo1-ORF2 struc-
ture did not reveal any homolog structure with a Z score higher
than 3.9. The most similar structure is the C-terminal domain of
DUF199/WhiA from Thermatoga maritima (Kaiser et al., 2009)
(PDB: 3HYI; Z = 3.9, rmsd = 4.1). 3D structural alignment
showed that the sequences from both structures only partially
aligned, including the first a helices from both structures and
the third a helix from AvrRxo1-ORF2, and the fourth a helix
from the C-terminal domain of DUF199/WhiA (Figures S5A and
S5C). The AvrRxo1-ORF2 structure represents a new protein
fold comprised of four a helices. The first and longest a helix
is key to tetramer formation by forming hydrogen bonds, salt
bridges, and hydrophobic interactions between two AvrRxo1-
ORF2 molecules in the complex. a Helices two to four and the
loop/turn links between them bind to the predicted substrate-
binding cavity of the AvrRxo1-ORF1 molecule (Figure S5B;
Tables S1 and S2), and this structural feature represents a prob-
able new kinase-binding domain. Although AvrRxo1-ORF2 is
encoded downstream of a T3S effector and produces an
effector-binding protein, our previous work showed that it is
not essential for translocation into host cells (Zhao et al.,
2004b), and this study revealed that AvrRxo1-ORF2 has no
structural similarity to characterized T3S effector chaperones.
Therefore, we hypothesize that AvrRxo1-ORF2 is not a typical
T3E-binding chaperone, and may instead function as an anti-
toxin to protect the bacteria from the bacteriostatic activity of
AvrRxo1-ORF1. Since bacterial T3Es are usually unfolded and
dissociated from their chaperones or co-factors before moving
through the narrow conduit of the TTSS (Akeda and Galan,
2005), we speculate that ORF2 also dissociates from AvrRxo1-
ORF1 before AvrRxo1-ORF1 is translocated into plant cells.
However, further study is needed to determine whether -ORF2
can be secreted and whether it has any activities to facilitate
the ORF1 secretion.
Concluding Remarks
We characterized the Xanthomonas T3S effector AvrRxo1-
ORF1 using structural biology and plant transient assayll rights reserved
Figure 4. Polynucleotide Substrate Binding in T4pnk and AvrRxo1-
ORF1
(A), T4pnk is shown in surface presentation, and colored according to elec-
trostatic property. Positive potentials are drawn in blue and negative potentials
in red. The single-strand trinucleotide, GTC binding site of T4pnk was gener-
ated from the T4pnk:GTC complex structure (PDB: 1RC8). GTC is shown as
sticks, with carbon (yellow), oxygen (red), nitrogen (blue), and phosphorus
(orange) atoms.
(B) GTC binding site in AvrRxo1-ORF1 was obtained by protein-DNA docking.
AvrRxo1-ORF1 is shown in surface presentation and colored to show its
electrostatic property. GTC is shown as sticks, with carbon (green), oxygen
(red), nitrogen (blue), hydrogen (gray), and phosphorus (orange) atoms.
See also Figure S2.methods. AvrRxo1-ORF1 folds into three domains: the N-ter-
minal region (residue 87–151), a central domain that contains
the ATP-binding site (residue 152–322), and a C-terminal
domain (residue 323–421). AvrRxo1-ORF1 forms a heterote-
tramer with AvrRxo1-ORF2, in which -ORF2 binds to the cen-
tral kinase domain of AvrRxo1-ORF1. AvrRxo1-ORF1 inhibits
bacterial growth in a manner dependent on the catalytic
and ATP-binding sites predicted by similarity to T4pnk do-
mains. An X. oryzae strain expressing wild-type AvrRxo1-
ORF1-ORF2 demonstrated enhanced bacterial proliferation
in rice plants, and the bacterial strain expressing a
AvrRxo1-T167N mutant was diminished in that ability, further
suggesting that the predicted kinase activity of AvrRxo1-
ORF1 is important to its function. Based on its cross-kingdom
functional activity and structural similarity to polynucleotide ki-
nases, it is possible that AvrRxo1-ORF1 targets a universally
important oligonucleotide or nucleotide sugar as a substrate.
To date, plant-pathogen T3Es are known to act as proteases,
phosphatases, acetyltransferases, ubiquitin ligases, nucleotide
transferases, phosphothreonine lyases, and transcriptional ac-
tivators (Deslandes and Rivas, 2012; Wirthmueller et al.,
2013). Modifying phosphorylation states of signaling proteins
is a common mechanism of suppressing plant effector-trig-
gered immunity, and several effectors act to block phosphor-
ylation or remove phosphate groups from host proteins (Block
et al., 2008). AvrB and AvrRpm1 increase phosphorylation of
RIN4 through the host kinase RIPK (Chung et al., 2011; Liu
et al., 2011), but are not thought to act as kinases them-
selves. The finding that AvrRxo1 has a T4pnk domain
provides intriguing evidence that an effector might directly
phosphorylate a host target, although demonstration of
AvrRxo1 kinase activity will be needed to demonstrate this
conclusively.Structure 23, 1900–EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of AvrRxo1-ORF1:ORF2
Complex
DNA fragments containing AvrRxo1-ORF1 (65–421 amino acids [aa]) and
AvrRxo1-ORF2 genes (Zhao et al., 2004b) were amplified from the genomic
DNA of X. oryzae pv. oryzicola strain BLS256 and cloned into pENTR-D-
TOPO vector (Invitrogen) (primers are listed in Table S3). The N-terminal 65
amino acids, presumed to encode a secretion signal, were omitted in purifi-
cation experiments. The AvrRxo1-ORF1 (65–421 aa) and AvrRxo1-ORF2
genes were subcloned into a modified pGEX4T-1 destination vector through
LR Gateway cloning (Invitrogen), where a ccdB cassette was inserted into
the BamHI and SalI sites in pGEX4T-1 (GE Healthcare Biosciences). To facil-
itate the removal of glutathione S-transferase (GST) tag, we also introduced a
tobacco etch virus protease cleavage site between GST and the targeted
protein. The resulting plasmid was transformed into E. coli C41 cells (Luci-
gen) and grown overnight in 50 ml of LB medium containing 100 mg/l ampi-
cillin at 37C. The culture was transferred into 2 l of LB medium containing
100 mg/l ampicillin to reach an A600 of 0.8 units. Isopropyl-1-thio-b-D-galac-
topyranoside (IPTG) was added to a final concentration of 1 mM with subse-
quent incubation at 250 rpm at 28C for 8 hr. The bacterial cells were
harvested and the cell pellets were broken by incubating with 1 mg/ml lyso-
zyme on ice for 1 hr, followed by sonication on ice. The lysate was centri-
fuged at 12,000 3 g for 20 min at 4C, and the supernatant was gently
collected and used for subsequent purification. A glutathione Sepharose
4B (GenScript) affinity resin, Q-Sepharose ion-exchange column was used
to purify the complex. The purity of the purified proteins was evaluated
both by 12% SDS-PAGE and 8% native PAGE. Protein concentration was
determined by a protein assay kit from Bio-Rad using BSA as a standard.
Selenomethionine-substituted proteins were produced in the same strain of
E. coli. The incorporation of selenomethionine into the recombinant proteins
was accomplished by using a special medium, Selenomethionine Expression
Media (Medicilon). The purification of selenomethionine-containing AvrRxo1-
ORF1:ORF2 complex followed the same protocols as those of the unmodi-
fied complexes.
X-Ray Crystallography
Diffraction-quality crystals of N-AvrRxo1-ORF1:AvrRxo1-ORF2 (native pro-
tein) and Se-Met-AvrRxo1-ORF1:AvrRxo1-ORF2 (selenomethionine-labeled)
were obtained using the hanging-drop method with initial droplets created
by mixing 1 ml of protein (10.0 mg/ml) with 1 ml of a crystallization solution
composed of 0.8 M NaH2PO4, 0.8 M KH2PO4, 15% glycerol, 8 mM DTT, and
0.1MHEPES (pH 7.5). Crystals of SO4-AvrRxo1-ORF1:AvrRxo1-ORF2 (sulfate
complex) were obtained using the same method in a different crystallization
buffer (1.6 M (NH4)2SO4, 18% glycerol, 8 mM DTT, 100 mM Na-citrate [pH
5.0]). ATP-AvrRxo1-ORF1:AvrRxo1-ORF2 (co-crystallized with ATP and mag-
nesium acetate) was co-crystallized with 30 mM ATP and 60 mM magnesium
acetate in the same buffer as for SO4-AvrRxo1-ORF1:AvrRxo1-ORF2 crystals.
All crystals appeared after 2 days at 22C.
Data Collection and Processing
Diffraction data of crystals were collected at the Brookhaven National Syn-
chrotron Light Source beamline X29A (l = 0.9790 A˚ or l = 1.075 A˚). Data
were collected using an ADSC Q315 CCD detector. All data were indexed
and integrated using HKL-2000 software. Scaling and merging of diffraction
data were performed using the program SCALEPACK (Otwinowski and Mi-
nor, 1997). The parameters of the crystals and data collection are listed in
Table 1.
Structure Determination
The structure of Se-Met-AvrRxo1-ORF1:AvrRxo1-ORF2 complex was deter-
mined by the SAD phasing technique with selenium anomalous signals.
Heavy-atom sites were located using hkl2map (Pape and Schneider, 2004)
and the initial SAD phases were calculated by PHENIX.Autosol (Adams
et al., 2010). Initial models were built using PHENIX.AutoBuild (Adams et al.,
2010). The model was refined using SAD refinement with optimization of the
selenium occupancy in Refmac 5.2 (Murshudov et al., 1997). Final models
were produced after numerous iterative rounds of manual rebuilding in Coot1909, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1905
Figure 5. Functional Assay ofWild-Type and
Mutant AvrRxo1
(A) Wild-type AvrRxo1, but not AvrRxo1-
ORF1:AvrRxo1-ORF2 or mutant AvRxo1-ORF1,
inhibits bacterial growth. E. coli strains carrying
pDEST527-AvrRxo1-ORF1,AvrRxo1-ORF1-T167N,
AvrRxo1-ORF1-D193T, or AvrRxo1-ORF1:ORF2
were grown at 37C in LB liquid medium. Protein
expression was induced by adding 0.5 mM IPTG.
Bacterial growth wasmonitored by dilution plating.
The mean data of three replicates are presented
(mean ±SD; n = 3).
(B) Transient expression of AvrRxo1, but not
AvrRxo1-T167N, triggered a cell death phenotype
in diverse plant species. Agrobacterium strain
GV2260 carrying construct pEarleyGate101-
AvrRxo1, pEarleyGate101-AvrRxo1-T167N, or
pEarleyGate101-GFP (A600 = 0.4), was infiltrated
into the leaf tissue of wild-type tobacco (Nicotiana
benthamiana), eggplant (Solanum melongena cv.
Black Beauty), pepper (Capsicum annuum cv.
ECW), and lettuce (Lactuca sativa cv. Giant
Caesar). Photographs were taken 3 days after
inoculation.
(C) Co-expression of AvrRxo1-ORF2 with
AvrRxo1-ORF1 suppressed the cell death pheno-
type. Agrobacterium strain GV2260 carrying
construct pEarleyGate101-AvrRxo1-ORF1 alone
(A600 = 0.4) or mixed equally with a suspension of
Agrobacterium carryingpEarleyGate202-AvrRxo1-
ORF2, were infiltrated into the leaf tissue of
N. benthamiana, and the responses were photo-
graphed 3 days after inoculation.
(D) Expression of wild-type AvrRxo1 in Xanthomo-
nas enhanced bacterial proliferation on rice plants.
Leaves of rice variety Kitaake were inoculated with
derivatives of X. oryzae strain X11-5A carrying
pHM1-AvrRxo1, pHM1-AvrRxo1-T167N, or the
empty vector pHM1. Bacterial multiplication in
leaves was determined in triplicate at 0 and 2 days
after inoculation. The means ± SE (n = 9; p < 0.01,
Student’s t test; different letters indicate significant
difference) are presented.
See also Figure S4.(Emsley and Cowtan, 2004) and refinement in Refmac 5.2. The structures of
native AvrRxo1-ORF1:AvrRxo1-ORF2 complexeswere determined by themo-
lecular replacement method using the solved structure as a starting model.
The programs MOLREP (Vagin and Teplyakov, 1997) and Phaser (McCoy
et al., 2007) were employed to calculate both cross-rotation and translation
of the model. The initial model was subjected to iterative cycles of crystallo-
graphic refinement with the Refmac 5.2 and graphic sessions for model build-
ing using the program Coot (Emsley and Cowtan, 2004). Solvent molecules
were automatically added and refined with ARP/wARP (Perrakis et al., 1997)
together with Refmac 5.2.1906 Structure 23, 1900–1909, October 6, 2015 ª2015 Elsevier Ltd All rights reservedMolecular Docking
To obtain insight into ATP binding of AvrRxo1-
ORF1, AutoDock Vina was used for molecular
docking (Trott and Olson, 2010). ATP molecules
for AutoDock Vina were prepared using Marvin
5.3.7, 2010 (ChemAxon) (http://www.chemaxon.
com). AutoDock Tools 1.5.4 (http://mgltools.
scripps.edu/documentation/how-to/citing-pmv-
adt-and-vision) were used to prepare the ligand
and receptor, after which docking was performedusing AutoDock Vina. All protein side chains were immobilized, and the
rotatable bonds were left free to rotate for the ATP molecule. The x, y, and z
dimensions of the grid were set based on phosphate- and sulfate-binding sites
in the putative ATP-binding sites revealed by similar ATP-binding protein
(T4pnk) in the AvrRxo1-ORF1:AvrRxo1-ORF2 complex structure. The grid
box covered the whole cavity. The lowest-energy configuration was consid-
ered the best docking pose for ATP. Protein-DNA docking was performed
with default parameters using the web server version of HADDOCK (de Vries
et al., 2010). The HADDOCK score was used to rank the generated poses.
It is a weighted sum of intermolecular electrostatic, van der Waals,
desolvation, and ambiguous interaction restraint energies. The final structures
were then clustered using the pairwise backbone rmsd at the interface using a
7.5-A˚ cutoff. The top-ranked cluster based on the HADDOCK scores is the
most reliable, and the first complex from cluster 1 was used in the comparison
of the binding sites of a single-strand nucleotide, GTC in AvrRxo1-ORF1 and
T4pnk (Eastberg et al., 2004).
Structure Analysis
Superposition of structures was done using Lsqkab (Kabsch, 1976) in the
CCP4 suite. Figures were generated using PyMOL (DeLano, 2002). Protein
surface properties were analyzed using PyMO (DeLano, 2002). 3D structural
alignment was made using STRAP (Gille and Frommel, 2001).
Plasmid Construction and Site-Directed Mutagenesis in Function
Studies
Wild-type AvrRxo1-ORF1 (corresponding to residues 65–421) and AvrRxo1-
ORF2 were amplified from p1-9 (Zhao et al., 2004b) with primers listed in SI
text, and cloned into pENTR-D-Topo (Invitrogen). This TopoEntrD-AvrRxo1-
ORF1 construct was used to develop AvrRxo1-ORF1 variants using primers
listed in Table S4. For Agrobacterium-mediated transient assays, wild-type
or mutant AvrRxo1-ORF1-T167N was cloned into the Gateway-compatible
pEarleyGate101, and AvrRxo1-ORF2 was cloned into pEarleyGate202
through LR cloning (Earley et al., 2006), whereby the targeted genes were
driven by the CaMV35S promoter.
For the plant infection assay, avrRxo1-ORF1-avrRxo1-ORF2 variants were
subcloned into a broad-host-range vector, pHM1 (Zhao et al., 2004b). pHM1-
AvrRxo1-ORF1-T167N, carrying AvrRxo1-ORF1 and ORF2 with a T167N
ATPase site substitution in AvrRxo1-ORF1, was generated by cloning the
SphI fragment from pHM1-AvrRxo1-ORF1 (Zhao et al., 2004b) into the vector
pGEM T-Easy (Promega, Madison, WI). The site-directed mutation was intro-
duced using primers AvrRxo1-ORF1_T167N forward and AvrRxo1-
ORF1_T167N reverse. The SphI fragment was cloned into pHM1 for X. oryzae
expression. Electrotransformation was used to transfer plasmid DNA (empty
vector pHM1, pHM1-AvrRxo1-ORF1 [T167N], and pHM1-AvrRxo1-ORF1)
into X. oryzae strain X11-5A as described previously (Zhao et al., 2004b).
Monitoring the Growth Rates of E. coli Strains Expressing AvrRxo1
The AvrRxo1-ORF1, AvrRxo1-ORF1:ORF2, AvrRxo1-ORF1-D193T, and
AvrRxo1-ORF1-T167 were cloned into the Gateway-compatible pDEST527
(Addgene.org) and expressed in E. coli strain BL21(DE3). Strains were grown at
37C in LB liquidmedium supplemented with 100 mg/ml ampicillin. The bacterial
culturewasdiluted toA600 =0.01, andexpressionwas inducedbyadding0.5mM
IPTG. The controls were the bacterial cultures without induction. The bacterial
growth was monitored by dilution plating. The mean data of three replicates
were presented, and experimentswere repeated three times with similar results.
Plant Disease Assay and Agrobacterium-Mediated Transient Assay
X. oryzae strain X11-5A is a weakly virulent strain isolated in the United States,
andwas used to expresswild-type andmutant AvrRxo1-ORF1-T167N for inoc-
ulation on rice cv. Kitaake plants. For bacterial population studies, 4-week-old
rice plants (cv. Kitaake) grown in a growth chamber were inoculated with deriv-
atives of X. oryzae strain X11-5A carrying pHM1, pHM1-AvrRxo1-ORF1:ORF2,
or pHM1-AvrRxo1-ORF1-T167N:ORF2 as described previously (Zhao et al.,
2005). Bacterial multiplication in the leaves was determined in triplicate at
0 and 2 days after inoculation. Leaf samples were surface-sterilized, ground
in 1 ml of sterile ddH2O, serially diluted, and plated on nutrient agar (Zhao
et al., 2004b). The experiments were repeated three times with similar results.
Agrobacterium tumefaciens GV2260 was used for transient expression in
Nicotiana benthamiana. Agrobacterium strains carrying different constructs
were adjusted to A600 = 0.4, and used to infiltrate plant mesophyll tissue using
the blunt end of syringes without needles as described previously (Zhao et al.,
2011). The plant cell death phenotype was photographed at 3 days after
inoculation.
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